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Multiple Sclerosis (MS) affects young adults and is characterized by chronic 
inflammation and demyelination in the central nervous system that leads to 
progressive worsening of disease. The cause of MS is incompletely 
understood and there is a need for more specific and effective treatments. 
 
This thesis aimed to characterize genetically controlled pathogenic 
mechanisms in the model of MS, experimental autoimmune 
encephalomyelitis (EAE), and to translate findings from experimental models 
to human disease. 
 
We demonstrated that genetic risk factors and pathogenic mechanisms in EAE 
are similar to those of MS. The EAE-susceptible strain had increased 
expression of MS candidate genes Il2ra and Il7r among others and up-
regulation of MS-associated immunological pathways such as TH1 and TH17. 
Expression of Il18r1 was increased in both the susceptible strain and in 
periphery and cerebrospinal fluid of MS patients. This might contribute 
pathogenically to disease through T cell differentiation and activation. 
Clinically isolated syndrome (CIS) patients had elevated IL18R1 expression, 
thus it could potentially serve as an early disease biomarker. 
 
Using an expression quantitative trait loci (eQTL) approach we detected 
numerous cis-regulated positional candidate genes for EAE and defined 
several disease correlated gene networks enriched for pathways involved in 
cell-mediated immune mechanisms of relevance for both EAE and MS. Mfsd4 
was identified as a candidate gene for Eae34 which conferred a functional 
effect on T cell proliferation and activation. The importance of autophagy 
related genes in the pathogenesis of neuroinflammation was investigated. 
Atg7 expression was higher in the EAE-resistant strain and in MS patients it 
associated with remission and less severe symptoms. 
 
Results presented in this thesis collectively demonstrate genetic regulation of 
known and novel mechanisms in EAE and MS and point to causal pathogenic 
pathways. Combining various research fields in both human cohorts and 
experimental models is a promising approach to increase our ability to define 
MS susceptibility genes and pathways to target for currently unfulfilled 
therapeutic needs. 
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